Latest Breaking News On - Prior to infinity pharmaceuticals - Page 1 : comparemela.com

/PRNewswire/ Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically.

United kingdomHenry pelishJames porterJohn sogliaNuvalent incTranslational developmentHarvard universityNortheastern universityCompany quarterly report on formInfinity pharmaceuticalsDrug developmentExchange commissionPrior to infinity pharmaceuticalsProfessor matthew shair at harvard universityProduct development scientificChief executive officer